Maestría en Gerencia de la Innovación y el Conocimiento · 2025
Biofarmacéuticas antioqueñas. Una mirada desde el management del conocimiento y la innovación
Antioquia is venturing into the biopharmaceutical industry with the aim of contributing to the treatment of chronic and emerging diseases worldwide. This sector, which is knowledge- and innovation-intensive, requires an intentional management approach to these two aspects, which represent challenges that have not yet been overcome in the region. The objective of this research was to construct a framework for Knowledge and Innovation Management (KIM) that would make visible the integration of fundamental elements for the successful development of biopharmaceutical solutions. This research adopted a qualitative approach. Data collection was conducted in two phases: a systematic literature review and field research. The literature review focused on articles and institutional reports published over the last three decades, with a focus on knowledge management and innovation in the biopharmaceutical sector, using academic databases and specific search terms. The field research consisted of semi-structured interviews with five opinion leaders from the biopharmaceutical sector in Antioquia, gathering their concepts and perceptions on the research topic. Finally, information from both phases was contrasted to identify the main challenges and propose a framework for action. The findings revealed that, despite efforts to articulate capabilities, the region faces deep-seated obstacles: disconnection among system actors, shortage of specialized professionals, regulatory and financial challenges, a system poorly harmonized with international standards, extensive regulatory processes, and lack of economic incentives. The study concluded that KIM is not considered or utilized as a strategic capability in Antioquia's biopharmaceutical companies. A framework for action is proposed that integrates technical elements (People, Processes, Technology, Governance) and ideological elements (Mindset, Trust, Leadership), whose systemic articulation is necessary for the sector's success.
Texto completo 67 páginas con texto
Leer la tesis completa Ficha en el repositorio
Contenido
- INTRODUCCIÓNp. 11
- JUSTIFICACIÓNp. 14
- OBJETIVOSp. 16
- GENERALp. 16
- ESPECÍFICOSp. 16
- ……………………………………………………………………...……………p. 17
- DEFINIENDO LAS BIOFARMACÉUTICASp. 17
- CONTEXTO GLOBAL Y LOCALp. 17
- BIOFARMACÉUTICAS EN LOS PAISES DESARROLLADOSp. 20
- MARCO DE REFERENCIA CONCEPTUALp. 26
- MANAGEMENTp. 26
- MANAGEMENT ESTRATÉGICOp. 29
- ASPECTOS METODOLÓGICOSp. 34
- EXPLORACION DE LITERATURAp. 34
- ANTIOQUEÑASp. 37
- PRESENTACIÓN Y ANÁLISIS DE RESULTADOSp. 39
- BIOFARMACEUTICA Y EL MC&Ip. 39
- INVESTIGACIÓN DE CAMPO. HALLAZGOS DE LAS ENTREVISTASp. 41
- 7.2.1. Patrones y síntesis de hallazgosp. 41
- 7.2.2. Diagnóstico y fallas en el MC&Ip. 47
- ANTIOQUIAp. 49
- 7.3.1. Fortalezas y Capacidadesp. 49
- 7.3.2. Desafíos de las biofarmacéuticas Antioqueñasp. 50
- PROPUESTA DE MARCO DE ACCIÓNp. 53
- 7.4.1. Fundamentos conceptuales del marco de acciónp. 53
- 7.4.2. Estructura del marco: elementos técnicos e ideológicosp. 54
- CONCLUSIONESp. 57
- REFERENCIASp. 60
- ANEXOS 1. INSTRUMENTO DESARROLLADO PARA LAS ENTREVISTASp. 64
- Tabla 5. Ecosistemas de I+D+ip. 44
- Excellence - HoKE).…………………………………………………………..………p. 32